Longevity.Technology clinical trials Survey

Question Title

* 1. PROFILE: Please tell us a little about yourself. This information is for research purposes only and we will 100% respect your privacy.

First name

Surname

Email address

Organisation name

*We are fully GDPR compliant, please check the privacy policy on our website for full details.

Question Title

* 2. COUNTRY: Where are you based?

Question Title

* 3. ROLE: What is your role?

Founder / joint-founder

Member of leadership team

Employee

Academic: lead researcher

Academic: research team member

Other (please specify)

Question Title

* 4. RAISE: What is your target investment for your next investment round?

Not fundraising

Less than $5000

$5000 to $10,000

$10,000 to $25,000

$25,000 to $50,000

$50,000 to $100,000

$100,000 to $250,000

$250,000 to $0.5m

$0.5m to $1m

$1m to $3m

$3m to $5m

$5m to $10m

$10m +

Question Title

* 5. COMPANY ABSTRACT: Please describe the disease areas and/or the fundamental aging pathology you are targeting with your innovation, as well as what population/s you are targeting

Disease area or fundamental aging pathology

Population you are targeting

Other relevant information

Question Title

* 6. TECH: What technology best categorises your business? (Please select at least one option):

Combination therapy

Small molecule

Biologic

Cell therapy

Genetic or epigenetic therapy

Nutritional intervention

Digital therapeutic

Other lifestyle intervention

Surgical intervention

Diagnostic

Prognostic

Therapeutic medical device

Other (please specify)

Question Title

* 7. CHALLENGES: What challenges are you facing in your venture currently and how are you resolving them?

	Not applicable	Haven't created solution yet	Hiring a consultant to resolve	Hiring a CRO to resolve	Speaking to our advisors
Test/therapy selection	Test/therapy selection Not applicable	Test/therapy selection Haven't created solution yet	Test/therapy selection Hiring a consultant to resolve	Test/therapy selection Hiring a CRO to resolve	Test/therapy selection Speaking to our advisors
Manufacturing of the test/therapy	Manufacturing of the test/therapy Not applicable	Manufacturing of the test/therapy Haven't created solution yet	Manufacturing of the test/therapy Hiring a consultant to resolve	Manufacturing of the test/therapy Hiring a CRO to resolve	Manufacturing of the test/therapy Speaking to our advisors
Cell/tissue studies	Cell/tissue studies Not applicable	Cell/tissue studies Haven't created solution yet	Cell/tissue studies Hiring a consultant to resolve	Cell/tissue studies Hiring a CRO to resolve	Cell/tissue studies Speaking to our advisors
Non-human animal studies	Non-human animal studies Not applicable	Non-human animal studies Haven't created solution yet	Non-human animal studies Hiring a consultant to resolve	Non-human animal studies Hiring a CRO to resolve	Non-human animal studies Speaking to our advisors
Human studies	Human studies Not applicable	Human studies Haven't created solution yet	Human studies Hiring a consultant to resolve	Human studies Hiring a CRO to resolve	Human studies Speaking to our advisors
Market demand/business model	Market demand/business model Not applicable	Market demand/business model Haven't created solution yet	Market demand/business model Hiring a consultant to resolve	Market demand/business model Hiring a CRO to resolve	Market demand/business model Speaking to our advisors
Going too slowly	Going too slowly Not applicable	Going too slowly Haven't created solution yet	Going too slowly Hiring a consultant to resolve	Going too slowly Hiring a CRO to resolve	Going too slowly Speaking to our advisors
Team lacks scientific or medical expertise	Team lacks scientific or medical expertise Not applicable	Team lacks scientific or medical expertise Haven't created solution yet	Team lacks scientific or medical expertise Hiring a consultant to resolve	Team lacks scientific or medical expertise Hiring a CRO to resolve	Team lacks scientific or medical expertise Speaking to our advisors
Team communication	Team communication Not applicable	Team communication Haven't created solution yet	Team communication Hiring a consultant to resolve	Team communication Hiring a CRO to resolve	Team communication Speaking to our advisors
Team too small	Team too small Not applicable	Team too small Haven't created solution yet	Team too small Hiring a consultant to resolve	Team too small Hiring a CRO to resolve	Team too small Speaking to our advisors
Team operations	Team operations Not applicable	Team operations Haven't created solution yet	Team operations Hiring a consultant to resolve	Team operations Hiring a CRO to resolve	Team operations Speaking to our advisors
Regulatory approval	Regulatory approval Not applicable	Regulatory approval Haven't created solution yet	Regulatory approval Hiring a consultant to resolve	Regulatory approval Hiring a CRO to resolve	Regulatory approval Speaking to our advisors
Cashflow (need more money)	Cashflow (need more money) Not applicable	Cashflow (need more money) Haven't created solution yet	Cashflow (need more money) Hiring a consultant to resolve	Cashflow (need more money) Hiring a CRO to resolve	Cashflow (need more money) Speaking to our advisors
Intellectual property	Intellectual property Not applicable	Intellectual property Haven't created solution yet	Intellectual property Hiring a consultant to resolve	Intellectual property Hiring a CRO to resolve	Intellectual property Speaking to our advisors

Other (please specify)

Question Title

* 8. URGENCY: How urgently do you need to address these challenges (overall) to progress your plans?

Not urgent

Very urgent

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 9. CLINICAL STUDIES: Have you done any clinical studies yet?

Yes